 Dennis Roop
Concepts (809)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epidermis | 82 | 2022 | 149 | 9.000 |
Why?
| | Keratins | 110 | 2016 | 176 | 7.140 |
Why?
| | Keratinocytes | 52 | 2022 | 216 | 4.290 |
Why?
| | Skin Neoplasms | 55 | 2019 | 761 | 4.290 |
Why?
| | Membrane Proteins | 39 | 2022 | 1022 | 4.100 |
Why?
| | Skin | 48 | 2020 | 659 | 3.360 |
Why?
| | Trans-Activators | 26 | 2013 | 368 | 3.100 |
Why?
| | Phosphoproteins | 17 | 2013 | 299 | 2.290 |
Why?
| | Cell Differentiation | 73 | 2020 | 1699 | 2.270 |
Why?
| | Papilloma | 31 | 2011 | 43 | 2.270 |
Why?
| | Cell Transformation, Neoplastic | 25 | 2016 | 312 | 2.240 |
Why?
| | NF-E2-Related Factor 2 | 7 | 2022 | 71 | 2.080 |
Why?
| | Mice, Transgenic | 64 | 2017 | 1951 | 2.050 |
Why?
| | Hyperkeratosis, Epidermolytic | 15 | 2008 | 20 | 2.050 |
Why?
| | Mice | 181 | 2020 | 14916 | 1.980 |
Why?
| | Stem Cells | 18 | 2017 | 546 | 1.900 |
Why?
| | Genes, ras | 25 | 2012 | 91 | 1.650 |
Why?
| | Animals | 223 | 2020 | 31761 | 1.650 |
Why?
| | Hair Follicle | 14 | 2020 | 44 | 1.500 |
Why?
| | Genetic Therapy | 12 | 2014 | 257 | 1.400 |
Why?
| | Mutation | 35 | 2018 | 3349 | 1.230 |
Why?
| | Point Mutation | 13 | 2009 | 216 | 1.190 |
Why?
| | Skin Diseases | 8 | 2014 | 122 | 1.150 |
Why?
| | Carcinoma, Squamous Cell | 20 | 2016 | 584 | 1.110 |
Why?
| | Transforming Growth Factor alpha | 10 | 2000 | 53 | 1.010 |
Why?
| | Ichthyosis | 7 | 2016 | 12 | 0.980 |
Why?
| | Mice, Knockout | 32 | 2018 | 2582 | 0.970 |
Why?
| | Induced Pluripotent Stem Cells | 5 | 2018 | 182 | 0.970 |
Why?
| | Cell Division | 19 | 2016 | 759 | 0.940 |
Why?
| | Disease Models, Animal | 29 | 2020 | 3542 | 0.930 |
Why?
| | Melanoma | 10 | 2020 | 629 | 0.930 |
Why?
| | Gene Expression Regulation | 30 | 2016 | 2321 | 0.920 |
Why?
| | Ectodermal Dysplasia | 5 | 2009 | 15 | 0.910 |
Why?
| | Phenotype | 26 | 2021 | 2811 | 0.910 |
Why?
| | DNA-Binding Proteins | 15 | 2015 | 1314 | 0.910 |
Why?
| | Cornified Envelope Proline-Rich Proteins | 7 | 2018 | 10 | 0.900 |
Why?
| | Morphogenesis | 7 | 2010 | 161 | 0.900 |
Why?
| | Vitiligo | 6 | 2020 | 52 | 0.870 |
Why?
| | Base Sequence | 48 | 2016 | 2118 | 0.870 |
Why?
| | Genes, fos | 10 | 2000 | 33 | 0.850 |
Why?
| | Gene Expression Regulation, Developmental | 13 | 2015 | 799 | 0.850 |
Why?
| | Neoplasms, Experimental | 4 | 2019 | 152 | 0.840 |
Why?
| | Transgenes | 13 | 2016 | 170 | 0.830 |
Why?
| | Ultraviolet Rays | 8 | 2018 | 366 | 0.830 |
Why?
| | Genes, p53 | 10 | 2012 | 62 | 0.830 |
Why?
| | Gene Expression Regulation, Neoplastic | 18 | 2015 | 1147 | 0.820 |
Why?
| | Tetradecanoylphorbol Acetate | 21 | 2010 | 153 | 0.820 |
Why?
| | Tumor Suppressor Proteins | 8 | 2009 | 282 | 0.810 |
Why?
| | Tumor Suppressor Protein p53 | 6 | 2011 | 447 | 0.800 |
Why?
| | Collagen Type VII | 1 | 2021 | 13 | 0.780 |
Why?
| | Jews | 1 | 2021 | 18 | 0.770 |
Why?
| | Epidermolysis Bullosa Dystrophica | 1 | 2021 | 21 | 0.760 |
Why?
| | Intermediate Filament Proteins | 22 | 2012 | 65 | 0.760 |
Why?
| | Skin Physiological Phenomena | 7 | 2008 | 26 | 0.750 |
Why?
| | Melanocytes | 6 | 2020 | 55 | 0.750 |
Why?
| | Neoplastic Stem Cells | 7 | 2016 | 334 | 0.730 |
Why?
| | Cells, Cultured | 37 | 2020 | 3890 | 0.720 |
Why?
| | Cell Lineage | 5 | 2010 | 310 | 0.700 |
Why?
| | Transcription Factors | 16 | 2015 | 1528 | 0.680 |
Why?
| | Ichthyosis, Lamellar | 2 | 2016 | 10 | 0.670 |
Why?
| | Intravital Microscopy | 1 | 2019 | 23 | 0.670 |
Why?
| | Cytoskeletal Proteins | 9 | 2012 | 145 | 0.670 |
Why?
| | Genes, myc | 4 | 2011 | 47 | 0.650 |
Why?
| | Proto-Oncogene Proteins c-myc | 5 | 2010 | 115 | 0.640 |
Why?
| | Signal Transduction | 22 | 2020 | 4521 | 0.640 |
Why?
| | Pluripotent Stem Cells | 2 | 2010 | 63 | 0.610 |
Why?
| | Molecular Sequence Data | 33 | 2012 | 2791 | 0.610 |
Why?
| | Hair | 6 | 2012 | 65 | 0.610 |
Why?
| | Hedgehog Proteins | 7 | 2017 | 173 | 0.600 |
Why?
| | Immunity, Cellular | 1 | 2019 | 248 | 0.590 |
Why?
| | Genes | 15 | 2008 | 224 | 0.590 |
Why?
| | Skin Diseases, Genetic | 6 | 2020 | 10 | 0.580 |
Why?
| | Keratin-6 | 5 | 2016 | 6 | 0.560 |
Why?
| | Head and Neck Neoplasms | 5 | 2016 | 436 | 0.550 |
Why?
| | Protein Isoforms | 8 | 2008 | 339 | 0.540 |
Why?
| | Humans | 125 | 2021 | 114716 | 0.530 |
Why?
| | Multipotent Stem Cells | 3 | 2010 | 18 | 0.530 |
Why?
| | Amino Acid Sequence | 30 | 2012 | 1988 | 0.530 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2016 | 123 | 0.510 |
Why?
| | Promoter Regions, Genetic | 16 | 2016 | 1133 | 0.510 |
Why?
| | Viral Proteins | 4 | 2002 | 281 | 0.510 |
Why?
| | Keratoderma, Palmoplantar | 3 | 2014 | 5 | 0.500 |
Why?
| | Transforming Growth Factor beta | 8 | 2009 | 449 | 0.500 |
Why?
| | Pachyonychia Congenita | 3 | 2014 | 4 | 0.490 |
Why?
| | Genetic Vectors | 7 | 2013 | 291 | 0.490 |
Why?
| | Cell Proliferation | 13 | 2016 | 2196 | 0.490 |
Why?
| | Tretinoin | 11 | 2014 | 125 | 0.480 |
Why?
| | Animals, Newborn | 23 | 2007 | 777 | 0.470 |
Why?
| | Cadherins | 3 | 2016 | 176 | 0.470 |
Why?
| | Mice, Mutant Strains | 12 | 2016 | 271 | 0.470 |
Why?
| | Epithelium | 14 | 2004 | 297 | 0.470 |
Why?
| | Keratosis | 7 | 2000 | 13 | 0.470 |
Why?
| | Cell Culture Techniques | 3 | 2014 | 343 | 0.470 |
Why?
| | Cell Cycle | 3 | 2012 | 543 | 0.460 |
Why?
| | DNA | 24 | 2018 | 1351 | 0.460 |
Why?
| | Ultraviolet Therapy | 3 | 2020 | 16 | 0.450 |
Why?
| | Amniotic Fluid | 2 | 2012 | 64 | 0.450 |
Why?
| | Proteomics | 2 | 2016 | 843 | 0.450 |
Why?
| | Mice, Inbred ICR | 10 | 2011 | 109 | 0.450 |
Why?
| | Genes, Dominant | 6 | 2016 | 94 | 0.440 |
Why?
| | Gene Deletion | 7 | 2012 | 356 | 0.430 |
Why?
| | Nails, Malformed | 2 | 2005 | 5 | 0.420 |
Why?
| | Up-Regulation | 8 | 2020 | 812 | 0.420 |
Why?
| | Transcription, Genetic | 23 | 2017 | 1316 | 0.420 |
Why?
| | Carcinoma, Basal Cell | 2 | 2017 | 68 | 0.420 |
Why?
| | Abnormalities, Multiple | 3 | 2014 | 177 | 0.420 |
Why?
| | Eyelids | 2 | 2009 | 29 | 0.420 |
Why?
| | Cleft Lip | 2 | 2009 | 32 | 0.410 |
Why?
| | Transforming Growth Factor beta2 | 1 | 2012 | 31 | 0.410 |
Why?
| | Melanoma, Experimental | 3 | 1998 | 89 | 0.410 |
Why?
| | Adaptor Proteins, Signal Transducing | 3 | 2012 | 368 | 0.400 |
Why?
| | Cleft Palate | 2 | 2009 | 46 | 0.400 |
Why?
| | 9,10-Dimethyl-1,2-benzanthracene | 16 | 2010 | 22 | 0.400 |
Why?
| | Mutation, Missense | 3 | 2016 | 295 | 0.390 |
Why?
| | Oncogene Proteins v-fos | 6 | 1999 | 11 | 0.390 |
Why?
| | DNA Primers | 12 | 2010 | 514 | 0.390 |
Why?
| | Mosaicism | 4 | 2014 | 61 | 0.390 |
Why?
| | Carcinogens | 11 | 2010 | 105 | 0.390 |
Why?
| | Calcium | 12 | 2010 | 1103 | 0.380 |
Why?
| | Apoptosis | 9 | 2012 | 2369 | 0.380 |
Why?
| | Wnt Signaling Pathway | 1 | 2012 | 147 | 0.370 |
Why?
| | RNA, Messenger | 35 | 2016 | 2557 | 0.370 |
Why?
| | Proteins | 3 | 2016 | 912 | 0.370 |
Why?
| | Centrosome | 4 | 2012 | 60 | 0.370 |
Why?
| | Pedigree | 11 | 2000 | 464 | 0.360 |
Why?
| | Keratin-10 | 7 | 2016 | 7 | 0.360 |
Why?
| | Alleles | 7 | 2016 | 791 | 0.360 |
Why?
| | Integrases | 5 | 2004 | 116 | 0.350 |
Why?
| | Immunotherapy | 3 | 2020 | 475 | 0.350 |
Why?
| | Stem Cell Niche | 1 | 2010 | 42 | 0.350 |
Why?
| | Female | 71 | 2021 | 59486 | 0.340 |
Why?
| | Gene Targeting | 5 | 2008 | 75 | 0.340 |
Why?
| | Transcription Factor AP-2 | 2 | 2008 | 81 | 0.330 |
Why?
| | Genes, Recessive | 2 | 2021 | 73 | 0.320 |
Why?
| | Skin Pigmentation | 2 | 2020 | 39 | 0.320 |
Why?
| | Wound Healing | 4 | 2010 | 258 | 0.320 |
Why?
| | Polymerase Chain Reaction | 12 | 2000 | 994 | 0.300 |
Why?
| | Disease Progression | 6 | 2019 | 2384 | 0.300 |
Why?
| | Mice, Inbred Strains | 13 | 2010 | 396 | 0.300 |
Why?
| | Keratins, Type II | 1 | 2007 | 2 | 0.300 |
Why?
| | Lipid Metabolism | 5 | 2018 | 446 | 0.300 |
Why?
| | Adenoviridae | 3 | 1998 | 185 | 0.300 |
Why?
| | Fluorescent Antibody Technique | 19 | 2004 | 396 | 0.290 |
Why?
| | Epidermolysis Bullosa Simplex | 3 | 2004 | 9 | 0.290 |
Why?
| | Aurora Kinases | 3 | 2012 | 28 | 0.290 |
Why?
| | Octamer Transcription Factor-3 | 1 | 2007 | 16 | 0.280 |
Why?
| | Mice, Nude | 11 | 2016 | 635 | 0.280 |
Why?
| | Aurora Kinase A | 3 | 2012 | 52 | 0.280 |
Why?
| | Transcription Factor AP-1 | 3 | 2014 | 80 | 0.280 |
Why?
| | Mice, Inbred BALB C | 17 | 2020 | 1151 | 0.280 |
Why?
| | Amino Acid Substitution | 4 | 2000 | 262 | 0.270 |
Why?
| | Mice, Inbred C57BL | 18 | 2015 | 4710 | 0.270 |
Why?
| | Models, Biological | 8 | 2016 | 1630 | 0.270 |
Why?
| | Proto-Oncogenes | 1 | 2006 | 26 | 0.270 |
Why?
| | Ichthyosiform Erythroderma, Congenital | 2 | 2018 | 5 | 0.270 |
Why?
| | Male | 47 | 2021 | 55558 | 0.270 |
Why?
| | Homeostasis | 3 | 2020 | 575 | 0.260 |
Why?
| | Genes, Reporter | 4 | 2009 | 257 | 0.260 |
Why?
| | Genomic Instability | 4 | 2011 | 38 | 0.260 |
Why?
| | Hyperplasia | 9 | 1999 | 163 | 0.260 |
Why?
| | Cell Line | 14 | 2018 | 2639 | 0.260 |
Why?
| | Lipids | 4 | 2018 | 582 | 0.260 |
Why?
| | Kelch-Like ECH-Associated Protein 1 | 3 | 2016 | 8 | 0.260 |
Why?
| | Oncogene Protein p21(ras) | 4 | 2004 | 16 | 0.250 |
Why?
| | Mouth Neoplasms | 2 | 2004 | 70 | 0.250 |
Why?
| | Gene Expression | 12 | 2015 | 1420 | 0.250 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 5 | 2015 | 229 | 0.240 |
Why?
| | Keratin-1 | 2 | 2016 | 2 | 0.240 |
Why?
| | Skin Diseases, Vesiculobullous | 2 | 1999 | 17 | 0.240 |
Why?
| | Intermediate Filaments | 6 | 2015 | 46 | 0.240 |
Why?
| | Prenatal Diagnosis | 2 | 1998 | 167 | 0.240 |
Why?
| | ras Proteins | 4 | 2013 | 138 | 0.240 |
Why?
| | beta Catenin | 3 | 2020 | 220 | 0.240 |
Why?
| | Protein Precursors | 9 | 2006 | 119 | 0.240 |
Why?
| | Retinoids | 2 | 1997 | 31 | 0.230 |
Why?
| | Heterozygote | 4 | 2010 | 251 | 0.230 |
Why?
| | Sequence Analysis, DNA | 6 | 2016 | 728 | 0.220 |
Why?
| | Mifepristone | 8 | 2009 | 60 | 0.220 |
Why?
| | Cocarcinogenesis | 4 | 2000 | 14 | 0.220 |
Why?
| | Lac Operon | 2 | 2000 | 44 | 0.220 |
Why?
| | Transfection | 10 | 2017 | 870 | 0.220 |
Why?
| | Transduction, Genetic | 4 | 2009 | 113 | 0.210 |
Why?
| | Skin Transplantation | 5 | 2016 | 57 | 0.210 |
Why?
| | Antioxidants | 2 | 2020 | 530 | 0.210 |
Why?
| | Proto-Oncogene Proteins | 5 | 2013 | 610 | 0.210 |
Why?
| | Oncogenes | 5 | 1994 | 107 | 0.210 |
Why?
| | Cilia | 2 | 2017 | 162 | 0.210 |
Why?
| | Cytoskeleton | 8 | 1994 | 177 | 0.210 |
Why?
| | Gene Transfer Techniques | 3 | 2000 | 147 | 0.210 |
Why?
| | Wnt Proteins | 3 | 2010 | 135 | 0.210 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 5 | 2010 | 928 | 0.200 |
Why?
| | Alopecia | 4 | 2005 | 28 | 0.200 |
Why?
| | Cell Membrane | 7 | 2015 | 679 | 0.200 |
Why?
| | Hindlimb | 2 | 1999 | 130 | 0.200 |
Why?
| | Chromosome Mapping | 5 | 2016 | 489 | 0.200 |
Why?
| | Chile | 1 | 2021 | 16 | 0.190 |
Why?
| | Colombia | 1 | 2021 | 34 | 0.190 |
Why?
| | Permeability | 3 | 2016 | 148 | 0.190 |
Why?
| | I-kappa B Kinase | 4 | 2009 | 50 | 0.190 |
Why?
| | RNA | 6 | 2018 | 810 | 0.190 |
Why?
| | Mexico | 1 | 2021 | 162 | 0.190 |
Why?
| | Molecular Imprinting | 1 | 2020 | 4 | 0.190 |
Why?
| | Carcinoma | 5 | 1995 | 198 | 0.180 |
Why?
| | Neoplasm Transplantation | 6 | 2016 | 232 | 0.180 |
Why?
| | Epithelial Cells | 13 | 2006 | 955 | 0.180 |
Why?
| | Keratin-14 | 4 | 2012 | 12 | 0.180 |
Why?
| | Ceramides | 3 | 2016 | 92 | 0.180 |
Why?
| | Regenerative Medicine | 2 | 2019 | 41 | 0.180 |
Why?
| | Adult Stem Cells | 1 | 2020 | 32 | 0.180 |
Why?
| | Antineoplastic Agents | 5 | 2016 | 1895 | 0.180 |
Why?
| | Laser Capture Microdissection | 2 | 2017 | 23 | 0.170 |
Why?
| | Zebrafish Proteins | 1 | 2002 | 246 | 0.170 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2008 | 271 | 0.170 |
Why?
| | Blotting, Western | 8 | 2007 | 1151 | 0.170 |
Why?
| | Papillomaviridae | 3 | 2016 | 102 | 0.170 |
Why?
| | Cell Membrane Permeability | 1 | 2020 | 83 | 0.170 |
Why?
| | Molecular Weight | 15 | 1990 | 331 | 0.170 |
Why?
| | Immunologic Surveillance | 1 | 2019 | 19 | 0.170 |
Why?
| | Precancerous Conditions | 4 | 2004 | 158 | 0.170 |
Why?
| | Arginine | 2 | 2007 | 236 | 0.170 |
Why?
| | Bimatoprost | 1 | 2019 | 3 | 0.170 |
Why?
| | Guided Tissue Regeneration | 1 | 2019 | 13 | 0.170 |
Why?
| | Janus Kinase Inhibitors | 1 | 2019 | 10 | 0.170 |
Why?
| | Genetic Linkage | 4 | 1999 | 297 | 0.170 |
Why?
| | Alopecia Areata | 1 | 2019 | 9 | 0.170 |
Why?
| | Crosses, Genetic | 4 | 2010 | 140 | 0.170 |
Why?
| | Tongue | 1 | 1999 | 67 | 0.160 |
Why?
| | Skin Aging | 2 | 1997 | 19 | 0.160 |
Why?
| | Cloning, Molecular | 8 | 2000 | 524 | 0.160 |
Why?
| | Xenograft Model Antitumor Assays | 3 | 2020 | 706 | 0.160 |
Why?
| | Threonine | 1 | 1999 | 40 | 0.160 |
Why?
| | Asparagine | 1 | 1999 | 29 | 0.160 |
Why?
| | Thymidine Kinase | 2 | 1998 | 14 | 0.160 |
Why?
| | Zinc Finger Protein GLI1 | 2 | 2017 | 21 | 0.160 |
Why?
| | Deafness | 1 | 2000 | 79 | 0.160 |
Why?
| | Ovalbumin | 7 | 1981 | 161 | 0.160 |
Why?
| | Tumor Cells, Cultured | 7 | 2016 | 854 | 0.160 |
Why?
| | Caspase 14 | 1 | 2018 | 1 | 0.160 |
Why?
| | Simplexvirus | 2 | 1998 | 80 | 0.160 |
Why?
| | Microscopy, Immunoelectron | 4 | 2016 | 43 | 0.150 |
Why?
| | Proto-Oncogene Proteins c-jun | 2 | 1999 | 47 | 0.150 |
Why?
| | Cytoprotection | 1 | 2018 | 51 | 0.150 |
Why?
| | Cellular Reprogramming Techniques | 1 | 2018 | 11 | 0.150 |
Why?
| | Transplantation, Heterologous | 3 | 2011 | 183 | 0.150 |
Why?
| | Gene Silencing | 2 | 2016 | 172 | 0.150 |
Why?
| | Microscopy, Electron | 9 | 2002 | 410 | 0.150 |
Why?
| | Caspase 3 | 2 | 2010 | 236 | 0.150 |
Why?
| | Mammary Glands, Animal | 2 | 2006 | 116 | 0.150 |
Why?
| | Potoroidae | 2 | 2007 | 3 | 0.150 |
Why?
| | Oncogene Proteins, Viral | 2 | 1994 | 20 | 0.150 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 3 | 2013 | 213 | 0.140 |
Why?
| | Desmosomes | 2 | 2016 | 20 | 0.140 |
Why?
| | Protein Multimerization | 1 | 2018 | 159 | 0.140 |
Why?
| | Receptors, Retinoic Acid | 1 | 1997 | 50 | 0.140 |
Why?
| | Syndrome | 3 | 2009 | 334 | 0.140 |
Why?
| | Exons | 2 | 2016 | 303 | 0.140 |
Why?
| | Receptors, Transforming Growth Factor beta | 1 | 1997 | 52 | 0.140 |
Why?
| | Fibroblasts | 5 | 2018 | 838 | 0.140 |
Why?
| | Dermatitis, Atopic | 1 | 2020 | 307 | 0.140 |
Why?
| | Mutagenesis, Site-Directed | 4 | 1999 | 345 | 0.140 |
Why?
| | Neovascularization, Pathologic | 1 | 1998 | 283 | 0.140 |
Why?
| | Glucosylceramides | 1 | 2016 | 6 | 0.140 |
Why?
| | Nucleic Acid Hybridization | 13 | 1991 | 187 | 0.140 |
Why?
| | Phosphatidylinositol 3-Kinase | 1 | 2016 | 27 | 0.140 |
Why?
| | Kallikreins | 1 | 2016 | 30 | 0.140 |
Why?
| | Recombinant Fusion Proteins | 2 | 1996 | 617 | 0.140 |
Why?
| | Bone Morphogenetic Protein 4 | 2 | 2014 | 34 | 0.130 |
Why?
| | Epithelial-Mesenchymal Transition | 3 | 2013 | 168 | 0.130 |
Why?
| | Gene Amplification | 2 | 2011 | 97 | 0.130 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 1999 | 333 | 0.130 |
Why?
| | SOXB1 Transcription Factors | 1 | 2016 | 61 | 0.130 |
Why?
| | Side-Population Cells | 2 | 2013 | 9 | 0.130 |
Why?
| | Microscopy, Fluorescence | 5 | 2007 | 398 | 0.130 |
Why?
| | Amino Acid Motifs | 1 | 2016 | 198 | 0.130 |
Why?
| | Genes, Regulator | 2 | 1993 | 34 | 0.130 |
Why?
| | Aldehyde Dehydrogenase | 2 | 2016 | 134 | 0.130 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2016 | 132 | 0.130 |
Why?
| | Hematopoietic Stem Cells | 3 | 2015 | 345 | 0.130 |
Why?
| | Cetuximab | 1 | 2015 | 91 | 0.130 |
Why?
| | Hand Deformities, Congenital | 1 | 2014 | 8 | 0.120 |
Why?
| | Trachea | 4 | 1993 | 223 | 0.120 |
Why?
| | Chloracne | 1 | 2014 | 1 | 0.120 |
Why?
| | Cricetinae | 9 | 1994 | 254 | 0.120 |
Why?
| | Keratin-2 | 3 | 2000 | 3 | 0.120 |
Why?
| | Nuclear Proteins | 3 | 2006 | 592 | 0.110 |
Why?
| | RNA, Neoplasm | 6 | 1995 | 80 | 0.110 |
Why?
| | Genes, Tumor Suppressor | 2 | 2004 | 77 | 0.110 |
Why?
| | Dermis | 2 | 2010 | 30 | 0.110 |
Why?
| | Transcriptional Activation | 4 | 2007 | 337 | 0.110 |
Why?
| | Cellular Reprogramming | 1 | 2014 | 84 | 0.110 |
Why?
| | Recombination, Genetic | 2 | 2008 | 176 | 0.110 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2014 | 60 | 0.110 |
Why?
| | Vagina | 3 | 1994 | 146 | 0.110 |
Why?
| | Hormones | 2 | 1994 | 133 | 0.110 |
Why?
| | Embryonic and Fetal Development | 3 | 2002 | 94 | 0.110 |
Why?
| | Genetic Engineering | 2 | 2007 | 80 | 0.110 |
Why?
| | Smad4 Protein | 1 | 2013 | 34 | 0.110 |
Why?
| | DNA Mutational Analysis | 3 | 2018 | 372 | 0.110 |
Why?
| | Embryoid Bodies | 1 | 2013 | 7 | 0.110 |
Why?
| | Fatty Acid Transport Proteins | 1 | 2012 | 18 | 0.110 |
Why?
| | RNA Splice Sites | 1 | 2012 | 34 | 0.110 |
Why?
| | DNA Restriction Enzymes | 7 | 1998 | 54 | 0.100 |
Why?
| | Models, Animal | 4 | 2013 | 345 | 0.100 |
Why?
| | Keratins, Hair-Specific | 1 | 2012 | 1 | 0.100 |
Why?
| | Fetal Diseases | 1 | 1994 | 147 | 0.100 |
Why?
| | Polyploidy | 1 | 2012 | 17 | 0.100 |
Why?
| | Polymorphism, Restriction Fragment Length | 3 | 2004 | 65 | 0.100 |
Why?
| | Dermatology | 1 | 2014 | 86 | 0.100 |
Why?
| | Macromolecular Substances | 7 | 1992 | 200 | 0.100 |
Why?
| | Cell Separation | 2 | 2007 | 292 | 0.100 |
Why?
| | RNA, Small Interfering | 3 | 2012 | 543 | 0.100 |
Why?
| | Carrier Proteins | 2 | 2003 | 696 | 0.100 |
Why?
| | Binding Sites | 4 | 2006 | 1176 | 0.100 |
Why?
| | Tumor Microenvironment | 1 | 2015 | 433 | 0.100 |
Why?
| | MicroRNAs | 2 | 2015 | 601 | 0.100 |
Why?
| | Immunohistochemistry | 14 | 2007 | 1635 | 0.100 |
Why?
| | Cancer Vaccines | 3 | 1998 | 138 | 0.100 |
Why?
| | Embryo, Mammalian | 3 | 2010 | 214 | 0.100 |
Why?
| | Cell Movement | 4 | 2019 | 867 | 0.100 |
Why?
| | Cerebellar Ataxia | 1 | 2011 | 7 | 0.100 |
Why?
| | Neoplasms | 2 | 2006 | 2105 | 0.100 |
Why?
| | Immunocompetence | 1 | 2011 | 40 | 0.090 |
Why?
| | Biomarkers, Tumor | 7 | 2009 | 1053 | 0.090 |
Why?
| | Regulatory Sequences, Nucleic Acid | 3 | 1999 | 81 | 0.090 |
Why?
| | Introns | 4 | 2004 | 227 | 0.090 |
Why?
| | Epitopes | 3 | 1997 | 435 | 0.090 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2012 | 642 | 0.090 |
Why?
| | Carcinogenesis | 3 | 2021 | 180 | 0.090 |
Why?
| | Cell Count | 2 | 1991 | 305 | 0.090 |
Why?
| | Integrins | 1 | 2011 | 79 | 0.090 |
Why?
| | Sebaceous Glands | 1 | 2010 | 4 | 0.090 |
Why?
| | Keratolytic Agents | 1 | 2010 | 5 | 0.090 |
Why?
| | Ribosomal Proteins | 1 | 2011 | 70 | 0.090 |
Why?
| | Proto-Oncogene Proteins c-fos | 3 | 1999 | 164 | 0.090 |
Why?
| | Calcification, Physiologic | 1 | 2011 | 34 | 0.090 |
Why?
| | Decidua | 1 | 2010 | 23 | 0.090 |
Why?
| | Nevus | 1 | 2010 | 26 | 0.090 |
Why?
| | Polymorphism, Genetic | 1 | 1993 | 612 | 0.090 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2015 | 863 | 0.090 |
Why?
| | Adenocarcinoma, Sebaceous | 1 | 2010 | 1 | 0.090 |
Why?
| | Sebaceous Gland Neoplasms | 1 | 2010 | 2 | 0.090 |
Why?
| | Genetic Techniques | 2 | 2005 | 58 | 0.090 |
Why?
| | Genotype | 4 | 2015 | 1773 | 0.090 |
Why?
| | Mitochondria | 1 | 2015 | 751 | 0.090 |
Why?
| | Caspase 7 | 1 | 2010 | 20 | 0.090 |
Why?
| | Aneuploidy | 2 | 2007 | 85 | 0.090 |
Why?
| | Osteoblasts | 1 | 2011 | 106 | 0.090 |
Why?
| | In Situ Nick-End Labeling | 2 | 2007 | 119 | 0.090 |
Why?
| | Liver Regeneration | 1 | 2010 | 29 | 0.090 |
Why?
| | Organ Specificity | 4 | 2007 | 268 | 0.090 |
Why?
| | Gene Expression Profiling | 4 | 2015 | 1521 | 0.090 |
Why?
| | Teratoma | 1 | 2010 | 92 | 0.090 |
Why?
| | Arachidonate 12-Lipoxygenase | 1 | 2009 | 13 | 0.090 |
Why?
| | Mammary Neoplasms, Experimental | 1 | 1990 | 64 | 0.090 |
Why?
| | Uterus | 1 | 2010 | 192 | 0.080 |
Why?
| | Reactive Oxygen Species | 1 | 2012 | 536 | 0.080 |
Why?
| | Collagen | 2 | 1988 | 415 | 0.080 |
Why?
| | Oviducts | 9 | 1982 | 15 | 0.080 |
Why?
| | Selection, Genetic | 1 | 2011 | 243 | 0.080 |
Why?
| | Adult | 10 | 2020 | 30543 | 0.080 |
Why?
| | Non-Fibrillar Collagens | 1 | 1988 | 1 | 0.080 |
Why?
| | Down-Regulation | 4 | 2009 | 596 | 0.080 |
Why?
| | Muscle, Smooth | 1 | 1990 | 144 | 0.080 |
Why?
| | Bromodeoxyuridine | 2 | 1999 | 72 | 0.080 |
Why?
| | Pemphigoid, Bullous | 1 | 1988 | 7 | 0.080 |
Why?
| | Osteogenesis | 1 | 2011 | 183 | 0.080 |
Why?
| | Stress, Physiological | 1 | 2012 | 379 | 0.080 |
Why?
| | Receptor, Notch1 | 2 | 2006 | 61 | 0.080 |
Why?
| | Spindle Apparatus | 1 | 2009 | 87 | 0.080 |
Why?
| | Gene Knockdown Techniques | 1 | 2009 | 299 | 0.080 |
Why?
| | Foot | 1 | 2009 | 103 | 0.080 |
Why?
| | Receptors, Progesterone | 2 | 2002 | 319 | 0.080 |
Why?
| | beta-Galactosidase | 2 | 1999 | 62 | 0.080 |
Why?
| | Hand | 1 | 2009 | 134 | 0.080 |
Why?
| | Cell Line, Tumor | 5 | 2015 | 2725 | 0.080 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 3 | 2005 | 107 | 0.080 |
Why?
| | Genes, Lethal | 2 | 2008 | 26 | 0.080 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2010 | 386 | 0.080 |
Why?
| | Cell Death | 1 | 2009 | 322 | 0.070 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 1361 | 0.070 |
Why?
| | Hoof and Claw | 1 | 2007 | 6 | 0.070 |
Why?
| | Cytoplasmic Granules | 4 | 2002 | 82 | 0.070 |
Why?
| | Olfactory Mucosa | 1 | 2008 | 60 | 0.070 |
Why?
| | Protein Conformation | 6 | 1992 | 811 | 0.070 |
Why?
| | Disease Susceptibility | 4 | 2006 | 316 | 0.070 |
Why?
| | Protein Structure, Tertiary | 2 | 2007 | 797 | 0.070 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 1998 | 140 | 0.070 |
Why?
| | Langerhans Cells | 2 | 1997 | 11 | 0.070 |
Why?
| | Growth Substances | 2 | 1999 | 136 | 0.070 |
Why?
| | Caspase 9 | 1 | 2007 | 48 | 0.070 |
Why?
| | Neoplasm Proteins | 2 | 2006 | 385 | 0.070 |
Why?
| | Species Specificity | 3 | 2000 | 545 | 0.070 |
Why?
| | Chloramphenicol O-Acetyltransferase | 2 | 1999 | 38 | 0.070 |
Why?
| | Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2006 | 15 | 0.070 |
Why?
| | Cell Adhesion | 3 | 2015 | 430 | 0.070 |
Why?
| | Interleukin-1alpha | 2 | 2020 | 55 | 0.070 |
Why?
| | Ganciclovir | 2 | 1998 | 49 | 0.070 |
Why?
| | Glycine | 1 | 2007 | 152 | 0.070 |
Why?
| | Microscopy, Fluorescence, Multiphoton | 1 | 2007 | 66 | 0.070 |
Why?
| | Biological Assay | 1 | 2007 | 113 | 0.070 |
Why?
| | Lymphatic Metastasis | 1 | 2007 | 280 | 0.070 |
Why?
| | Twist-Related Protein 1 | 1 | 2006 | 10 | 0.070 |
Why?
| | Mice, SCID | 3 | 2013 | 320 | 0.070 |
Why?
| | Blotting, Northern | 6 | 1992 | 193 | 0.070 |
Why?
| | Phorbols | 1 | 1985 | 10 | 0.070 |
Why?
| | Darier Disease | 1 | 2005 | 2 | 0.060 |
Why?
| | Autoantigens | 1 | 1988 | 396 | 0.060 |
Why?
| | Oxidative Stress | 1 | 2012 | 1084 | 0.060 |
Why?
| | Antibodies | 2 | 1985 | 371 | 0.060 |
Why?
| | Stomach | 2 | 2006 | 101 | 0.060 |
Why?
| | Models, Genetic | 3 | 2008 | 565 | 0.060 |
Why?
| | Protein Structure, Secondary | 2 | 1999 | 325 | 0.060 |
Why?
| | Nucleic Acid Precursors | 3 | 1980 | 24 | 0.060 |
Why?
| | Recombinant Proteins | 2 | 1999 | 1233 | 0.060 |
Why?
| | Enzyme Activation | 1 | 2007 | 787 | 0.060 |
Why?
| | United States | 1 | 2021 | 12176 | 0.060 |
Why?
| | Cell Cycle Proteins | 2 | 2006 | 552 | 0.060 |
Why?
| | Cyclins | 2 | 1996 | 78 | 0.060 |
Why?
| | Cell Adhesion Molecules | 1 | 2006 | 168 | 0.060 |
Why?
| | Nerve Tissue Proteins | 1 | 1988 | 529 | 0.060 |
Why?
| | Skin Abnormalities | 2 | 2002 | 10 | 0.060 |
Why?
| | Pregnancy | 5 | 2010 | 5525 | 0.060 |
Why?
| | Embryonic Development | 1 | 2005 | 117 | 0.060 |
Why?
| | Sequence Analysis, RNA | 2 | 2017 | 388 | 0.060 |
Why?
| | Retinal Dehydrogenase | 2 | 2016 | 41 | 0.060 |
Why?
| | Homeodomain Proteins | 2 | 2006 | 463 | 0.060 |
Why?
| | RNA Interference | 3 | 2013 | 437 | 0.060 |
Why?
| | Calcineurin | 1 | 2005 | 89 | 0.060 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 4 | 1990 | 319 | 0.060 |
Why?
| | Transglutaminases | 3 | 1995 | 142 | 0.060 |
Why?
| | Biomarkers | 5 | 2004 | 3414 | 0.060 |
Why?
| | Blotting, Southern | 3 | 2001 | 68 | 0.060 |
Why?
| | In Vitro Techniques | 4 | 2013 | 1013 | 0.060 |
Why?
| | Time Factors | 5 | 2004 | 6124 | 0.060 |
Why?
| | Receptors, Cell Surface | 2 | 2005 | 354 | 0.060 |
Why?
| | Tissue Distribution | 2 | 2002 | 285 | 0.050 |
Why?
| | Flow Cytometry | 1 | 2007 | 1086 | 0.050 |
Why?
| | Vimentin | 4 | 1994 | 58 | 0.050 |
Why?
| | Molecular Structure | 2 | 1994 | 438 | 0.050 |
Why?
| | Genetic Variation | 2 | 1998 | 876 | 0.050 |
Why?
| | Dacarbazine | 2 | 2012 | 101 | 0.050 |
Why?
| | S100 Proteins | 2 | 2000 | 38 | 0.050 |
Why?
| | Keratin-15 | 1 | 2002 | 13 | 0.050 |
Why?
| | Keratin-5 | 1 | 2002 | 46 | 0.050 |
Why?
| | Mesocricetus | 5 | 1993 | 30 | 0.050 |
Why?
| | Immunoenzyme Techniques | 4 | 1993 | 195 | 0.050 |
Why?
| | 3T3 Cells | 3 | 2013 | 140 | 0.050 |
Why?
| | Vitamin A Deficiency | 3 | 1993 | 27 | 0.050 |
Why?
| | Bone and Bones | 1 | 2004 | 278 | 0.050 |
Why?
| | Luteolytic Agents | 1 | 2001 | 1 | 0.050 |
Why?
| | Administration, Topical | 3 | 1997 | 139 | 0.050 |
Why?
| | Autoantibodies | 1 | 1988 | 1350 | 0.050 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2004 | 398 | 0.050 |
Why?
| | Benzo(a)pyrene | 1 | 2000 | 7 | 0.050 |
Why?
| | Zebrafish | 1 | 2004 | 411 | 0.050 |
Why?
| | Response Elements | 2 | 2012 | 83 | 0.050 |
Why?
| | Rats | 5 | 1994 | 4943 | 0.050 |
Why?
| | Nuclear Localization Signals | 1 | 2000 | 14 | 0.050 |
Why?
| | Frameshift Mutation | 1 | 2000 | 27 | 0.050 |
Why?
| | NAD(P)H Dehydrogenase (Quinone) | 1 | 2000 | 31 | 0.050 |
Why?
| | Cell Compartmentation | 1 | 2000 | 51 | 0.050 |
Why?
| | Cell Survival | 3 | 2013 | 1021 | 0.050 |
Why?
| | Netherton Syndrome | 1 | 2020 | 2 | 0.050 |
Why?
| | Kidney | 1 | 2007 | 1184 | 0.050 |
Why?
| | Dermatitis, Exfoliative | 1 | 2020 | 4 | 0.050 |
Why?
| | Repressor Proteins | 2 | 2013 | 367 | 0.040 |
Why?
| | Chickens | 9 | 1995 | 177 | 0.040 |
Why?
| | Cell Nucleus | 7 | 2004 | 554 | 0.040 |
Why?
| | Potassium Channels, Voltage-Gated | 1 | 2020 | 48 | 0.040 |
Why?
| | Adaptation, Biological | 1 | 2000 | 54 | 0.040 |
Why?
| | Immunoblotting | 4 | 2003 | 283 | 0.040 |
Why?
| | rho GTP-Binding Proteins | 1 | 2020 | 61 | 0.040 |
Why?
| | Breast Neoplasms | 1 | 2011 | 1868 | 0.040 |
Why?
| | Estrenes | 1 | 1999 | 15 | 0.040 |
Why?
| | DNA, Complementary | 2 | 2003 | 257 | 0.040 |
Why?
| | DNA, Neoplasm | 3 | 1995 | 157 | 0.040 |
Why?
| | DNA Damage | 2 | 2012 | 357 | 0.040 |
Why?
| | Phototherapy | 1 | 2019 | 24 | 0.040 |
Why?
| | Genomic Library | 1 | 1999 | 15 | 0.040 |
Why?
| | Restriction Mapping | 1 | 1999 | 77 | 0.040 |
Why?
| | Genetic Carrier Screening | 1 | 1999 | 24 | 0.040 |
Why?
| | Forelimb | 1 | 1999 | 24 | 0.040 |
Why?
| | Cell Self Renewal | 1 | 2019 | 49 | 0.040 |
Why?
| | Protein Transport | 1 | 2000 | 396 | 0.040 |
Why?
| | Peptides | 1 | 1984 | 848 | 0.040 |
Why?
| | Reference Values | 3 | 2002 | 742 | 0.040 |
Why?
| | RNA, Heterogeneous Nuclear | 1 | 1978 | 4 | 0.040 |
Why?
| | Sequence Analysis | 1 | 1998 | 35 | 0.040 |
Why?
| | Fungal Proteins | 1 | 1999 | 119 | 0.040 |
Why?
| | Thrombospondin 1 | 1 | 1998 | 19 | 0.040 |
Why?
| | Dimerization | 1 | 1999 | 176 | 0.040 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 1998 | 61 | 0.040 |
Why?
| | Endothelial Growth Factors | 1 | 1998 | 50 | 0.040 |
Why?
| | Lymphokines | 1 | 1998 | 111 | 0.040 |
Why?
| | Antigens, Neoplasm | 2 | 1997 | 222 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2011 | 743 | 0.040 |
Why?
| | Body Patterning | 1 | 1999 | 126 | 0.040 |
Why?
| | Mutagenesis, Insertional | 1 | 1998 | 61 | 0.040 |
Why?
| | Psoriasis | 2 | 1996 | 74 | 0.040 |
Why?
| | Protein Binding | 3 | 2009 | 1896 | 0.040 |
Why?
| | Genes, bcl-2 | 1 | 1998 | 20 | 0.040 |
Why?
| | Age of Onset | 1 | 1999 | 447 | 0.040 |
Why?
| | Neovascularization, Physiologic | 1 | 1999 | 173 | 0.040 |
Why?
| | Biomechanical Phenomena | 1 | 2000 | 667 | 0.040 |
Why?
| | Genetic Predisposition to Disease | 1 | 2006 | 2099 | 0.040 |
Why?
| | Gamma Rays | 1 | 1998 | 48 | 0.040 |
Why?
| | Retinoic Acid Receptor alpha | 1 | 1997 | 11 | 0.040 |
Why?
| | Thymus Gland | 1 | 1998 | 296 | 0.040 |
Why?
| | Epidermal Growth Factor | 3 | 1993 | 162 | 0.040 |
Why?
| | Oxazines | 1 | 1997 | 25 | 0.040 |
Why?
| | Retinoid X Receptors | 1 | 1997 | 39 | 0.040 |
Why?
| | Mitotic Index | 1 | 1997 | 26 | 0.040 |
Why?
| | Metaplasia | 3 | 1993 | 54 | 0.040 |
Why?
| | Receptors, Calcitriol | 1 | 1997 | 53 | 0.040 |
Why?
| | Clinical Trials, Phase II as Topic | 1 | 1997 | 59 | 0.030 |
Why?
| | Hypertrophy | 1 | 1997 | 109 | 0.030 |
Why?
| | Interleukin-2 | 1 | 1998 | 417 | 0.030 |
Why?
| | Clinical Trials, Phase I as Topic | 1 | 1997 | 46 | 0.030 |
Why?
| | Carcinogenicity Tests | 2 | 1994 | 5 | 0.030 |
Why?
| | Hybrid Cells | 2 | 1994 | 49 | 0.030 |
Why?
| | Luciferases | 2 | 2009 | 142 | 0.030 |
Why?
| | Body Temperature | 1 | 1997 | 208 | 0.030 |
Why?
| | Organ Culture Techniques | 4 | 1990 | 141 | 0.030 |
Why?
| | Repetitive Sequences, Nucleic Acid | 2 | 1987 | 104 | 0.030 |
Why?
| | Hyaluronan Receptors | 1 | 2016 | 91 | 0.030 |
Why?
| | Extremities | 1 | 1997 | 113 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 1998 | 528 | 0.030 |
Why?
| | Spheroids, Cellular | 1 | 2016 | 58 | 0.030 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 1 | 1997 | 114 | 0.030 |
Why?
| | Rats, Inbred F344 | 2 | 1993 | 241 | 0.030 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 1998 | 498 | 0.030 |
Why?
| | Middle Aged | 5 | 2020 | 26746 | 0.030 |
Why?
| | Kinetics | 5 | 1994 | 1550 | 0.030 |
Why?
| | Rabbits | 2 | 1996 | 736 | 0.030 |
Why?
| | Phospholipids | 1 | 1997 | 197 | 0.030 |
Why?
| | Biopsy | 2 | 1997 | 1040 | 0.030 |
Why?
| | Maximum Tolerated Dose | 1 | 2015 | 184 | 0.030 |
Why?
| | Fluorescent Dyes | 1 | 1997 | 300 | 0.030 |
Why?
| | PAX3 Transcription Factor | 1 | 2015 | 11 | 0.030 |
Why?
| | Paired Box Transcription Factors | 1 | 2015 | 37 | 0.030 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 1995 | 152 | 0.030 |
Why?
| | Inhibins | 1 | 1995 | 45 | 0.030 |
Why?
| | Interleukins | 1 | 1997 | 236 | 0.030 |
Why?
| | Intramolecular Oxidoreductases | 1 | 2015 | 57 | 0.030 |
Why?
| | Random Allocation | 1 | 2016 | 335 | 0.030 |
Why?
| | Benzoates | 1 | 1995 | 38 | 0.030 |
Why?
| | Cantharidin | 1 | 1994 | 1 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 1998 | 1122 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2015 | 63 | 0.030 |
Why?
| | Ainhum | 1 | 2014 | 1 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2016 | 316 | 0.030 |
Why?
| | Tetrahydronaphthalenes | 1 | 1995 | 31 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2020 | 723 | 0.030 |
Why?
| | Lung Neoplasms | 1 | 2007 | 2199 | 0.030 |
Why?
| | DNA Probes, HPV | 1 | 1994 | 1 | 0.030 |
Why?
| | Evaluation Studies as Topic | 1 | 1994 | 168 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2020 | 9089 | 0.030 |
Why?
| | Sequence Alignment | 1 | 1995 | 325 | 0.030 |
Why?
| | Infant, Newborn | 2 | 2009 | 5035 | 0.030 |
Why?
| | Staining and Labeling | 2 | 2010 | 134 | 0.030 |
Why?
| | Actin Cytoskeleton | 1 | 1995 | 93 | 0.030 |
Why?
| | Ornithine Decarboxylase | 1 | 1994 | 9 | 0.030 |
Why?
| | Epigen | 1 | 2014 | 1 | 0.030 |
Why?
| | Secretory Leukocyte Peptidase Inhibitor | 1 | 2014 | 6 | 0.030 |
Why?
| | Open Reading Frames | 1 | 1994 | 116 | 0.030 |
Why?
| | Disease-Free Survival | 1 | 2015 | 623 | 0.030 |
Why?
| | Antigens, CD | 1 | 2016 | 443 | 0.030 |
Why?
| | Chorionic Villi | 1 | 1994 | 16 | 0.030 |
Why?
| | Protein Biosynthesis | 6 | 1991 | 385 | 0.030 |
Why?
| | Collagen Type IV | 1 | 2014 | 22 | 0.030 |
Why?
| | Child | 3 | 2020 | 18352 | 0.030 |
Why?
| | Simian virus 40 | 1 | 1993 | 22 | 0.030 |
Why?
| | TATA Box | 1 | 1993 | 22 | 0.030 |
Why?
| | Ovariectomy | 1 | 1994 | 116 | 0.030 |
Why?
| | Laminin | 1 | 1994 | 69 | 0.030 |
Why?
| | Integrin beta1 | 1 | 2013 | 16 | 0.030 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2016 | 359 | 0.030 |
Why?
| | alpha Catenin | 1 | 2013 | 13 | 0.030 |
Why?
| | Cholecalciferol | 1 | 1994 | 47 | 0.030 |
Why?
| | Constriction, Pathologic | 1 | 2014 | 208 | 0.030 |
Why?
| | Bone Marrow | 1 | 2015 | 244 | 0.030 |
Why?
| | Butylhydroxybutylnitrosamine | 1 | 1993 | 6 | 0.030 |
Why?
| | Clone Cells | 2 | 2010 | 248 | 0.030 |
Why?
| | Cell Dedifferentiation | 1 | 2013 | 28 | 0.030 |
Why?
| | Multigene Family | 1 | 1994 | 193 | 0.030 |
Why?
| | Inhibitor of Apoptosis Proteins | 1 | 2013 | 42 | 0.030 |
Why?
| | Viruses | 1 | 1994 | 94 | 0.030 |
Why?
| | Mice, Inbred CBA | 1 | 2013 | 53 | 0.030 |
Why?
| | Collagen Type I | 1 | 2014 | 108 | 0.030 |
Why?
| | Sulfur Radioisotopes | 2 | 1990 | 17 | 0.030 |
Why?
| | Glycoproteins | 1 | 1995 | 304 | 0.030 |
Why?
| | ErbB Receptors | 1 | 2016 | 560 | 0.030 |
Why?
| | DNA Probes | 2 | 1992 | 59 | 0.030 |
Why?
| | Sequence Deletion | 1 | 2013 | 167 | 0.030 |
Why?
| | Forecasting | 1 | 1994 | 331 | 0.030 |
Why?
| | Breast | 1 | 1993 | 141 | 0.030 |
Why?
| | Chromosomes, Mammalian | 1 | 2012 | 26 | 0.030 |
Why?
| | Lentivirus | 1 | 2013 | 45 | 0.030 |
Why?
| | Diseases in Twins | 1 | 1994 | 174 | 0.030 |
Why?
| | Serine | 1 | 1993 | 126 | 0.030 |
Why?
| | Aldehyde Oxidoreductases | 1 | 2012 | 31 | 0.030 |
Why?
| | Egg Proteins | 3 | 1982 | 19 | 0.030 |
Why?
| | Proteome | 1 | 2015 | 339 | 0.030 |
Why?
| | Bacteriophage lambda | 1 | 1993 | 81 | 0.030 |
Why?
| | Cysteine | 1 | 1993 | 171 | 0.030 |
Why?
| | Coloring Agents | 1 | 2012 | 72 | 0.020 |
Why?
| | Infant | 2 | 2009 | 7935 | 0.020 |
Why?
| | Limb Buds | 2 | 2004 | 20 | 0.020 |
Why?
| | Age Factors | 2 | 1996 | 2889 | 0.020 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 1997 | 689 | 0.020 |
Why?
| | Tritium | 3 | 1994 | 66 | 0.020 |
Why?
| | Isoenzymes | 1 | 2012 | 285 | 0.020 |
Why?
| | Myoepithelioma | 1 | 1991 | 2 | 0.020 |
Why?
| | Gene Knock-In Techniques | 1 | 2011 | 46 | 0.020 |
Why?
| | Mutagenicity Tests | 1 | 2011 | 9 | 0.020 |
Why?
| | Biological Evolution | 2 | 1985 | 416 | 0.020 |
Why?
| | Child, Preschool | 2 | 2009 | 9079 | 0.020 |
Why?
| | Avian Leukosis Virus | 1 | 2011 | 6 | 0.020 |
Why?
| | Hyperpigmentation | 1 | 2011 | 11 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2016 | 1690 | 0.020 |
Why?
| | Ovomucin | 2 | 1982 | 3 | 0.020 |
Why?
| | Integrin-Binding Sialoprotein | 1 | 2011 | 4 | 0.020 |
Why?
| | Haploinsufficiency | 1 | 2011 | 42 | 0.020 |
Why?
| | Progesterone | 2 | 2010 | 232 | 0.020 |
Why?
| | Rodent Diseases | 1 | 1991 | 25 | 0.020 |
Why?
| | Interleukin-8 | 1 | 2012 | 237 | 0.020 |
Why?
| | Paclitaxel | 1 | 2012 | 190 | 0.020 |
Why?
| | Pilot Projects | 1 | 2015 | 1370 | 0.020 |
Why?
| | Moloney murine leukemia virus | 1 | 1991 | 11 | 0.020 |
Why?
| | Transcriptome | 1 | 2016 | 727 | 0.020 |
Why?
| | Osteocalcin | 1 | 2011 | 34 | 0.020 |
Why?
| | Cytokines | 2 | 2015 | 1843 | 0.020 |
Why?
| | Embryo Implantation | 1 | 2010 | 23 | 0.020 |
Why?
| | T-Lymphocytes | 1 | 1998 | 1745 | 0.020 |
Why?
| | Wnt4 Protein | 1 | 2010 | 17 | 0.020 |
Why?
| | Immunosorbent Techniques | 2 | 1987 | 17 | 0.020 |
Why?
| | Growth Disorders | 1 | 2011 | 77 | 0.020 |
Why?
| | Swine | 1 | 1993 | 700 | 0.020 |
Why?
| | Mice, Inbred NOD | 1 | 2012 | 561 | 0.020 |
Why?
| | Urinary Bladder Neoplasms | 1 | 1993 | 196 | 0.020 |
Why?
| | Estrogens | 4 | 1982 | 312 | 0.020 |
Why?
| | DNA Repair | 1 | 2012 | 186 | 0.020 |
Why?
| | Mitosis | 1 | 2011 | 164 | 0.020 |
Why?
| | Pigmentation | 1 | 2010 | 55 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 1999 | 4420 | 0.020 |
Why?
| | Diagnosis, Differential | 1 | 1994 | 1340 | 0.020 |
Why?
| | Phospholipases A2 | 1 | 2010 | 76 | 0.020 |
Why?
| | Animals, Wild | 1 | 1990 | 44 | 0.020 |
Why?
| | Mouth Mucosa | 1 | 1990 | 79 | 0.020 |
Why?
| | Adenoma, Pleomorphic | 1 | 1990 | 8 | 0.020 |
Why?
| | Parotid Neoplasms | 1 | 1990 | 14 | 0.020 |
Why?
| | Amino Acids | 4 | 2002 | 448 | 0.020 |
Why?
| | Anemia | 1 | 2011 | 144 | 0.020 |
Why?
| | Smad3 Protein | 1 | 2009 | 41 | 0.020 |
Why?
| | Enzyme Induction | 1 | 2009 | 84 | 0.020 |
Why?
| | Arachidonic Acid | 1 | 2010 | 116 | 0.020 |
Why?
| | Mice, Inbred C3H | 1 | 1990 | 241 | 0.020 |
Why?
| | Imidazoles | 1 | 2010 | 211 | 0.020 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2010 | 139 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2016 | 3004 | 0.020 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2009 | 129 | 0.020 |
Why?
| | Cellular Senescence | 1 | 2010 | 152 | 0.020 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2009 | 83 | 0.020 |
Why?
| | Dinoprostone | 1 | 2010 | 184 | 0.020 |
Why?
| | Diethylstilbestrol | 2 | 1979 | 9 | 0.020 |
Why?
| | Dystonin | 1 | 1988 | 1 | 0.020 |
Why?
| | Lactation | 1 | 1990 | 151 | 0.020 |
Why?
| | Ameloblastoma | 1 | 1988 | 5 | 0.020 |
Why?
| | Cell Communication | 1 | 2010 | 279 | 0.020 |
Why?
| | Methionine | 1 | 1989 | 144 | 0.020 |
Why?
| | Tissue Scaffolds | 1 | 2011 | 179 | 0.020 |
Why?
| | Piperazines | 1 | 2010 | 311 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2009 | 445 | 0.020 |
Why?
| | gamma-Glutamyltransferase | 1 | 1988 | 42 | 0.020 |
Why?
| | Vitamin A | 2 | 1986 | 52 | 0.020 |
Why?
| | Organoids | 1 | 1988 | 74 | 0.020 |
Why?
| | Isoelectric Point | 1 | 1987 | 22 | 0.020 |
Why?
| | Antigens, Differentiation | 1 | 1988 | 80 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 797 | 0.020 |
Why?
| | Survival Analysis | 1 | 2010 | 1218 | 0.020 |
Why?
| | Interferon-gamma | 1 | 1990 | 722 | 0.020 |
Why?
| | Protease Inhibitors | 1 | 1988 | 97 | 0.020 |
Why?
| | Body Weight | 1 | 2011 | 869 | 0.020 |
Why?
| | Antigens, Ly | 1 | 1987 | 45 | 0.020 |
Why?
| | Harvey murine sarcoma virus | 1 | 1986 | 1 | 0.020 |
Why?
| | Dimethyl Sulfoxide | 1 | 1987 | 43 | 0.020 |
Why?
| | Interleukin-6 | 1 | 1990 | 675 | 0.020 |
Why?
| | Occludin | 1 | 2006 | 10 | 0.020 |
Why?
| | LIM Domain Proteins | 1 | 2006 | 13 | 0.020 |
Why?
| | Claudin-1 | 1 | 2006 | 21 | 0.020 |
Why?
| | Immunoassay | 1 | 1987 | 95 | 0.020 |
Why?
| | Minichromosome Maintenance Complex Component 7 | 1 | 2006 | 4 | 0.020 |
Why?
| | Olfactory Bulb | 1 | 2008 | 123 | 0.020 |
Why?
| | Receptors, Steroid | 1 | 2006 | 47 | 0.020 |
Why?
| | Aged | 3 | 2020 | 19079 | 0.020 |
Why?
| | Chemistry | 1 | 1985 | 38 | 0.020 |
Why?
| | Chemical Phenomena | 1 | 1985 | 80 | 0.020 |
Why?
| | Fluocinolone Acetonide | 1 | 1985 | 16 | 0.020 |
Why?
| | X-Ray Diffraction | 1 | 1985 | 84 | 0.020 |
Why?
| | Phosphorylation | 1 | 2009 | 1571 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2012 | 1892 | 0.020 |
Why?
| | HeLa Cells | 1 | 2007 | 562 | 0.020 |
Why?
| | Young Adult | 1 | 2020 | 10462 | 0.020 |
Why?
| | Protein Processing, Post-Translational | 1 | 1987 | 399 | 0.020 |
Why?
| | Microscopy, Electron, Scanning | 1 | 1985 | 192 | 0.020 |
Why?
| | Calcium-Binding Proteins | 1 | 1986 | 207 | 0.020 |
Why?
| | Erythroid-Specific DNA-Binding Factors | 1 | 2004 | 18 | 0.020 |
Why?
| | Cattle | 2 | 1988 | 921 | 0.020 |
Why?
| | Calcineurin Inhibitors | 1 | 2005 | 58 | 0.020 |
Why?
| | Liver | 1 | 1992 | 1631 | 0.020 |
Why?
| | YY1 Transcription Factor | 1 | 2004 | 27 | 0.020 |
Why?
| | NFATC Transcription Factors | 1 | 2005 | 78 | 0.020 |
Why?
| | Base Composition | 1 | 1984 | 75 | 0.010 |
Why?
| | Adolescent | 2 | 2020 | 17808 | 0.010 |
Why?
| | Hormone Antagonists | 1 | 2004 | 33 | 0.010 |
Why?
| | Antibodies, Monoclonal | 2 | 1990 | 1270 | 0.010 |
Why?
| | Thymidine | 2 | 1994 | 58 | 0.010 |
Why?
| | Antigen-Antibody Complex | 1 | 1984 | 88 | 0.010 |
Why?
| | Terminology as Topic | 1 | 1985 | 187 | 0.010 |
Why?
| | Fibroblast Growth Factor 8 | 1 | 2004 | 27 | 0.010 |
Why?
| | Receptors, Fibroblast Growth Factor | 1 | 2004 | 63 | 0.010 |
Why?
| | Extracellular Matrix | 1 | 1987 | 435 | 0.010 |
Why?
| | src-Family Kinases | 1 | 2004 | 88 | 0.010 |
Why?
| | Clinical Trials as Topic | 1 | 2008 | 934 | 0.010 |
Why?
| | Craniofacial Abnormalities | 1 | 2004 | 59 | 0.010 |
Why?
| | Weaning | 1 | 2003 | 48 | 0.010 |
Why?
| | Stomach Diseases | 1 | 2003 | 19 | 0.010 |
Why?
| | Interleukin-1 | 1 | 1988 | 966 | 0.010 |
Why?
| | Esophageal Diseases | 1 | 2003 | 24 | 0.010 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2003 | 61 | 0.010 |
Why?
| | Mice, Hairless | 2 | 1994 | 74 | 0.010 |
Why?
| | Coculture Techniques | 1 | 2003 | 201 | 0.010 |
Why?
| | Aging | 1 | 1993 | 1620 | 0.010 |
Why?
| | Fibroblast Growth Factors | 1 | 2004 | 162 | 0.010 |
Why?
| | Cheek | 2 | 1993 | 16 | 0.010 |
Why?
| | RNA, Small Nuclear | 1 | 1981 | 31 | 0.010 |
Why?
| | Mice, Inbred A | 1 | 2000 | 45 | 0.010 |
Why?
| | Biotransformation | 1 | 2000 | 49 | 0.010 |
Why?
| | Risk Factors | 1 | 1994 | 8626 | 0.010 |
Why?
| | Peptide Fragments | 1 | 1984 | 668 | 0.010 |
Why?
| | Neurons | 1 | 2008 | 1280 | 0.010 |
Why?
| | Limb Deformities, Congenital | 1 | 1999 | 8 | 0.010 |
Why?
| | Sequence Homology | 1 | 1999 | 39 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2003 | 1846 | 0.010 |
Why?
| | Phosphorus Radioisotopes | 1 | 1978 | 27 | 0.010 |
Why?
| | Globins | 1 | 1978 | 21 | 0.010 |
Why?
| | Cholera Toxin | 2 | 1988 | 27 | 0.010 |
Why?
| | Reticulocytes | 1 | 1978 | 16 | 0.010 |
Why?
| | Polyribosomes | 1 | 1978 | 22 | 0.010 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 1 | 1998 | 97 | 0.010 |
Why?
| | RNA Polymerase II | 1 | 1981 | 285 | 0.010 |
Why?
| | Antibody Specificity | 2 | 1989 | 176 | 0.010 |
Why?
| | DNA Fragmentation | 1 | 1998 | 47 | 0.010 |
Why?
| | Isotope Labeling | 1 | 1978 | 69 | 0.010 |
Why?
| | Drug Stability | 1 | 1978 | 151 | 0.010 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 1998 | 309 | 0.010 |
Why?
| | Immunologic Techniques | 2 | 1986 | 39 | 0.010 |
Why?
| | T-Lymphocyte Subsets | 1 | 1998 | 384 | 0.010 |
Why?
| | Desmogleins | 1 | 1996 | 5 | 0.010 |
Why?
| | Receptors, Estrogen | 1 | 1979 | 372 | 0.010 |
Why?
| | Desmoplakins | 1 | 1996 | 19 | 0.010 |
Why?
| | Follistatin | 1 | 1995 | 12 | 0.010 |
Why?
| | Activins | 1 | 1995 | 26 | 0.010 |
Why?
| | Musculoskeletal Abnormalities | 1 | 1995 | 10 | 0.010 |
Why?
| | Vibrissae | 1 | 1995 | 10 | 0.010 |
Why?
| | Palate | 1 | 1995 | 28 | 0.010 |
Why?
| | Xenopus | 1 | 1995 | 98 | 0.010 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 1998 | 618 | 0.010 |
Why?
| | Musculoskeletal System | 1 | 1995 | 43 | 0.010 |
Why?
| | Membrane Glycoproteins | 1 | 1997 | 429 | 0.010 |
Why?
| | Estrus | 1 | 1994 | 11 | 0.010 |
Why?
| | Acetone | 1 | 1994 | 10 | 0.010 |
Why?
| | Lymph Nodes | 1 | 1997 | 423 | 0.010 |
Why?
| | Skull | 1 | 1995 | 119 | 0.010 |
Why?
| | Dendritic Cells | 1 | 1997 | 436 | 0.010 |
Why?
| | Cell Fusion | 1 | 1993 | 50 | 0.010 |
Why?
| | Protein Kinase C | 1 | 1994 | 275 | 0.010 |
Why?
| | Organelles | 1 | 1991 | 51 | 0.010 |
Why?
| | Retroviridae | 1 | 1991 | 90 | 0.010 |
Why?
| | Cell Line, Transformed | 1 | 1991 | 133 | 0.010 |
Why?
| | Trypsin | 1 | 1990 | 67 | 0.010 |
Why?
| | Peptide Mapping | 1 | 1990 | 60 | 0.010 |
Why?
| | von Willebrand Factor | 1 | 1990 | 56 | 0.010 |
Why?
| | DNA, Recombinant | 2 | 1979 | 41 | 0.010 |
Why?
| | RNA Probes | 1 | 1988 | 13 | 0.010 |
Why?
| | Autoradiography | 1 | 1988 | 70 | 0.000 |
Why?
| | HLA-DR Antigens | 1 | 1990 | 220 | 0.000 |
Why?
| | Histocytochemistry | 1 | 1988 | 79 | 0.000 |
Why?
| | Metaphase | 1 | 1988 | 28 | 0.000 |
Why?
| | Light | 1 | 1990 | 336 | 0.000 |
Why?
| | Cysteine Proteinase Inhibitors | 1 | 1988 | 45 | 0.000 |
Why?
| | Cytoplasm | 1 | 1988 | 255 | 0.000 |
Why?
| | Microbial Collagenase | 1 | 1987 | 10 | 0.000 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 1 | 1988 | 101 | 0.000 |
Why?
| | Culture Techniques | 1 | 1987 | 78 | 0.000 |
Why?
| | Cross Reactions | 1 | 1988 | 117 | 0.000 |
Why?
| | Leukemia, Radiation-Induced | 1 | 1987 | 4 | 0.000 |
Why?
| | Proto-Oncogene Proteins c-sis | 1 | 1987 | 35 | 0.000 |
Why?
| | Leukemia, Experimental | 1 | 1987 | 27 | 0.000 |
Why?
| | Cricetulus | 1 | 1987 | 97 | 0.000 |
Why?
| | Inflammation | 1 | 1997 | 2481 | 0.000 |
Why?
| | Diterpenes | 1 | 1986 | 31 | 0.000 |
Why?
| | Genetic Markers | 1 | 1987 | 321 | 0.000 |
Why?
| | Incidence | 1 | 1991 | 2312 | 0.000 |
Why?
| | Aged, 80 and over | 1 | 1996 | 6346 | 0.000 |
Why?
| | Lipopolysaccharides | 1 | 1988 | 812 | 0.000 |
Why?
| | Poly A | 1 | 1982 | 46 | 0.000 |
Why?
| | DNA-Directed RNA Polymerases | 1 | 1979 | 51 | 0.000 |
Why?
| | Retrospective Studies | 1 | 1991 | 12513 | 0.000 |
Why?
|
|
Roop's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|